Lead Story
Parkinson’s drug slows progression of motor symptoms
A developmental drug has shown promise in slowing symptoms of motor deterioration in people with advanced forms of Parkinson’s.
Industry news
Novel antibiotic receives EMA’s recommendation
The European Medicines Agency has recommended marketing authorisation for an antibiotic which can treat multidrug-resistant infections.
Modified skin bacteria treats tumours in mice
A study from Stanford Medicine has developed a promising method to treat cancer using a type of bacteria which is found on skin.
Cutting antibiotic usage reduces resistance levels
Cutting the use of antibiotics in both humans and animals has shown a reduction in antimicrobial-resistant bacteria.
Utah law to permit non-FDA-approved stem cell therapies
Utah has passed legislation that will allow patients to receive placental stem cell therapies without the need for FDA approval.
More news
Sponge-on-a-string cuts wait time for Barrett’s diagnosis
MHRA reclassifies codeine linctus as prescription-only
Violin resin works as cleaning agent for ‘superbugs’
Angioedemas caused by rare gene fault curable by CRISPR
EMA platform to monitor use of antimicrobials
NHS Pharmacy First offers an alternative to GPs in England
AUS-UK joint agency vetmed approval process agreed
